World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

David Kelly Biography and Net Worth

Director of Mesa Laboratories

Mr. Kelly currently serves as a member of the Board of Directors of Mestek (OTC: MCCK), and a privately held company, and previously served on the Board of Directors of Federated Investors, Inc. (NYSE: FII). In 1995, Mr. Kelly joined Matthews International Corporation, where he served as Chairman of the Board, Chief Executive Officer and President until his retirement in 2007. From 1972 to 1995, Mr. Kelly was with Carrier Corporation and held a variety of executive positions, in the United States and in Asia, in marketing, finance, manufacturing and operations, including President of North America operations. He received a Bachelor of Science degree in Physics from Boston College in 1964, a Master’s degree in Molecular Biophysics from Yale in 1966, and a Master of Business Administration degree from Harvard Business School in 1968.

What is David M. Kelly's net worth?: The estimated net worth of David M. Kelly is at least $8.15 million as of December 11th, 2023. Mr. Kelly owns 80,097 shares of Mesa Laboratories stock worth more than $8,153,875 as of April 25th. This net worth estimate does not reflect any other assets that Mr. Kelly may own. Learn More about David M. Kelly's net worth.
How do I contact David M. Kelly?: The corporate mailing address for Mr. Kelly and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on David M. Kelly's contact information.
Has David M. Kelly been buying or selling shares of Mesa Laboratories?: David M. Kelly has not been actively trading shares of Mesa Laboratories during the past quarter. Most recently, David M. Kelly sold 18 shares of the business's stock in a transaction on Monday, November 8th. The shares were sold at an average price of $324.07, for a transaction totalling $5,833.26. Learn More on David M. Kelly's trading history.
Who are Mesa Laboratories' active insiders?: Mesa Laboratories' insider roster includes Brian Archbold (SVP), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), and John Sullivan (Director). Learn More on Mesa Laboratories' active insiders.
Are insiders buying or selling shares of Mesa Laboratories?: During the last twelve months, insiders at the medical instruments supplier sold shares 4 times. They sold a total of 7,500 shares worth more than $947,880.00. The most recent insider tranaction occured on December, 15th when SVP Brian David Archbold sold 1,500 shares worth more than $168,540.00. Insiders at Mesa Laboratories own 5.2% of the company. Learn More about insider trades at Mesa Laboratories.
Information on this page was last updated on 12/15/2023.

David M. Kelly Insider Trading History at Mesa Laboratories

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/8/2021	Sell	18	$324.07	$5,833.26
8/31/2021	Sell	603	$267.29	$161,175.87
6/4/2021	Sell	851	$260.28	$221,498.28	2,772
12/11/2020	Sell	250	$283.18	$70,795.00	2,350
11/16/2020	Sell	704	$283.31	$199,450.24	3,304
8/31/2020	Sell	600	$245.00	$147,000.00	2,990
8/28/2020	Sell	180	$244.00	$43,920.00	2,990
8/17/2020	Sell	800	$247.72	$198,176.00	3,610
8/10/2020	Sell	1,371	$250.00	$342,750.00	3,154
3/19/2019	Sell	684	$230.00	$157,320.00	3,584
2/6/2019	Sell	2,000	$229.62	$459,240.00	3,900
12/6/2018	Sell	1,700	$210.94	$358,598.00	3,600
9/13/2018	Sell	700	$190.01	$133,007.00	3,600
6/12/2017	Sell	1,000	$142.00	$142,000.00	4,750

David M. Kelly Buying and Selling Activity at Mesa Laboratories

Mesa Laboratories Company Overview

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Today's Range

Now: $101.80

$100.66

$103.46

50 Day Range

MA: $105.07

$99.40

$114.10

2 Week Range

Now: $101.80

$82.86

$172.80

Volume

24,278 shs

Average Volume

47,806 shs

Market Capitalization

$548.70 million

P/E Ratio

598.86

Dividend Yield

0.60%

Beta

0.83

World’s biggest multibillionaire investor is buying THIS by the ton [picture]

From Stansberry Research | Ad

Click here to find out what to do.